Axogen, Inc. (AXGN) stock
AXGNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/30144% above fair value
$55.93+0.53 (+0.96%)
Close on Nov 13, 2026Market cap $3.34BP/E –Yield –
Axogen enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Axogen's enterprise value was $3.03B on Nov 11, 2026, against $1.33B a year earlier. Over the last 5 years it ranged from $166.97M to $3.03B, with a median of $464.97M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $3.03B | +99.9% |
| 2025 | Dec 31, 2025 | $1.52B | +104.6% |
| 2024 | Dec 31, 2024 | $741.90M | +145.9% |
| 2023 | Dec 29, 2023 | $301.75M | -26.0% |
| 2022 | Dec 30, 2022 | $408.00M | +20.9% |
| 2021 | Dec 31, 2021 | $337.59M | -46.7% |
| 2020 | Dec 31, 2020 | $632.96M | +4.9% |
| 2019 | Dec 31, 2019 | $603.67M | -9.1% |
| 2018 | Dec 31, 2018 | $663.78M | -29.6% |
| 2017 | Dec 29, 2017 | $943.38M | +235.9% |
| 2016 | Dec 30, 2016 | $280.87M | +93.9% |
| 2015 | Dec 31, 2015 | $144.82M | +83.1% |
| 2014 | Dec 31, 2014 | $79.08M | -0.7% |
| 2013 | Dec 31, 2013 | $79.60M | +148.4% |
| 2012 | Dec 31, 2012 | $32.05M | +34.3% |
| 2011 | Dec 30, 2011 | $23.87M | – |
See a number that looks wrong?